Since colorectal cancer has shown different prognostic meaning for FOXP3+ Treg compared with other organs in previous studies28–30, and CD103+ immune cells are widely expressed in Tregs, the inclusion of some organs has the potential to shift the result. This evidence concerns the gene FOXP3 and colorectal cancer.